The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health ... inflated insulin list prices, ...

An FTC official said the case argues that PBMs ... a report refuting arguments that the industry raises costs. The drug middlemen say they’re a necessary counterweight to the unchecked ...

endangering patients,” said the FTC's Chair, Lina Khan. “Our inquiry requests information on the factors driving these shortages and scrutinises the practices of opaque drug middlemen.” ...

Now, the Federal Trade Commission (FTC) is suing three companies over allegedly inflating the cost of the drug at the expense ... benefit managers (PBMs), or middlemen, who handle most (at least ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

Elizabeth Warren seeks scrutiny of deals that would allow drug middlemen McKesson, Cardinal Health, and Cencora to also ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...

These prices have been exacerbated by pharmacy benefit managers, or PBMs, middlemen between drug manufacturers ... Scripts over their alleged role in incentivizing higher drug prices. The FTC believes ...

The drug middlemen say they’re a necessary counterweight to the unchecked power of pharmaceutical companies to set prices. The insulin market is dominated by three manufacturers: Eli Lilly & Co., ...